Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAZERTINIB for Egfr gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where LAZERTINIB was used for Egfr gene mutation.

Most Reported Side Effects for LAZERTINIB

Side Effect Reports % Deaths Hosp.
Rash 77 21.9% 0 3
Neuropathy peripheral 32 9.1% 0 0
Infusion related reaction 30 8.5% 1 6
Fatigue 26 7.4% 2 4
Diarrhoea 20 5.7% 0 4
Off label use 19 5.4% 0 5
Paronychia 16 4.6% 0 1
Pruritus 13 3.7% 0 0
Nausea 12 3.4% 1 2
Dyspnoea 11 3.1% 1 2
Oedema peripheral 11 3.1% 0 4
Hypoaesthesia 10 2.8% 0 1
Stomatitis 10 2.8% 0 1
Decreased appetite 9 2.6% 0 0
Non-small cell lung cancer 9 2.6% 1 1

Other Indications for LAZERTINIB

Non-small cell lung cancer (133) Product used for unknown indication (114) Lung neoplasm malignant (44) Non-small cell lung cancer metastatic (16) Lung adenocarcinoma stage iv (6) Lung carcinoma cell type unspecified recurrent (5)

Other Drugs Used for Egfr gene mutation

AFATINIB (780) OSIMERTINIB (695) GEFITINIB (97) AMIVANTAMAB-VMJW (89) ERLOTINIB (52) PEMETREXED (34) CARBOPLATIN (30) MOBOCERTINIB (26) BEVACIZUMAB (25) NINTEDANIB (24)

Related Pages

LAZERTINIB Full Profile All Egfr gene mutation Drugs LAZERTINIB Demographics LAZERTINIB Timeline